SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-19-020092
Filing Date
2019-05-22
Accepted
2019-05-21 21:56:20
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 life-s3.htm S-3 586232
2 EX-4.2 life-ex42_16.htm EX-4.2 430333
3 EX-4.3 life-ex43_17.htm EX-4.3 468728
4 EX-5.1 life-ex51_60.htm EX-5.1 24320
5 EX-23.1 life-ex231_61.htm EX-23.1 3030
6 GRAPHIC giejfv4epb2k000002.jpg GRAPHIC 4176
7 GRAPHIC giejfv4epb2k000001.jpg GRAPHIC 4176
8 GRAPHIC gov5koolm3e5000001.jpg GRAPHIC 25886
  Complete submission text file 0001564590-19-020092.txt   1561246
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-231658 | Film No.: 19843922
SIC: 2836 Biological Products, (No Diagnostic Substances)